Treatment and Prognosis for Small Invasive Breast Carcinoma

Pathological Assessment

The tumor is very small (2mm), which is classified as T1a (tumor >1mm but ≤5mm) 2

Breast-conserving surgery (lumpectomy) with sentinel lymph node biopsy is the standard approach for this small, early-stage tumor 3, 1
Proper orientation of the surgical specimen with markers is essential to ensure negative margins while preserving breast tissue 3, 4
Specimen radiography should be performed intraoperatively to confirm complete removal of any mammographic abnormalities 1
Sentinel lymph node biopsy is recommended for axillary staging, as this is an invasive carcinoma 2

Radiation therapy following breast-conserving surgery is generally recommended to reduce local recurrence risk 3, 1
Endocrine therapy should be considered if hormone receptor testing reveals ER/PR positivity 2, 5
For this very small (2mm) Grade 1 tumor, adjuvant chemotherapy is typically not indicated unless other high-risk features are present 2
Hormone receptor and HER2 status should be determined to guide adjuvant therapy decisions 4, 5

The 2mm tumor size is highly favorable, as tumor size directly correlates with prognosis 4, 1

Regular clinical examinations every 4-6 months for the first 5 years, then annually 1, 6
Annual mammography of both breasts 1, 6
No indication for intensive surveillance imaging (CT, bone scans, etc.) in this early-stage disease with excellent prognosis 5

Overtreatment with chemotherapy for very small, low-grade tumors that have excellent prognosis with local therapy alone 2, 1
Inadequate surgical margins leading to re-excision; proper specimen orientation and intraoperative assessment are critical 3, 1
Failure to perform hormone receptor and HER2 testing, which are essential for determining appropriate adjuvant therapy 4, 5